These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28275168)

  • 1. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
    Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
    Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
    [No Abstract]   [Full Text] [Related]  

  • 2. Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual.
    Tang C; Hess KR; Sanders D; Davis SE; Buzdar AU; Kurzrock R; Lee JJ; Meric-Bernstam F; Hong DS
    Clin Cancer Res; 2017 Mar; 23(6):1407-1413. PubMed ID: 27852698
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.
    Massett HA; Mishkin G; Rubinstein L; Ivy SP; Denicoff A; Godwin E; DiPiazza K; Bolognese J; Zwiebel JA; Abrams JS
    Clin Cancer Res; 2016 Nov; 22(22):5408-5416. PubMed ID: 27401246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2010 Nov; 16(22):5557-63. PubMed ID: 21062929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.
    Gerber DE; Lakoduk AM; Priddy LL; Yan J; Xie XJ
    Oncologist; 2015 Jun; 20(6):674-82. PubMed ID: 26018661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.
    Bennette CS; Ramsey SD; McDermott CL; Carlson JJ; Basu A; Veenstra DL
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26714555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2011 Apr; 17(7):1947-55. PubMed ID: 21447723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007.
    Korn EL; Freidlin B; Mooney M; Abrams JS
    J Clin Oncol; 2010 Dec; 28(35):5197-201. PubMed ID: 21060029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials.
    Peterson JS; Plana D; Bitterman DS; Johnson SB; Aerts HJWL; Kann BH
    Cancer Med; 2023 Feb; 12(4):4715-4724. PubMed ID: 36398619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
    Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
    WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
    Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
    Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.
    Mileham KF; Kim ES
    Clin Cancer Res; 2016 Nov; 22(22):5397-5399. PubMed ID: 27601589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.
    Zaren HA; Nair S; Go RS; Enos RA; Lanier KS; Thompson MA; Zhao J; Fleming DL; Leighton JC; Gribbin TE; Bryant DM; Carrigan A; Corpening JC; Csapo KA; Dimond EP; Ellison C; Gonzalez MM; Harr JL; Wilkinson K; Denicoff AM
    J Oncol Pract; 2013 Mar; 9(2):e55-61. PubMed ID: 23814525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.
    Schroen AT; Petroni GR; Wang H; Gray R; Wang XF; Cronin W; Sargent DJ; Benedetti J; Wickerham DL; Djulbegovic B; Slingluff CL
    Clin Trials; 2010 Aug; 7(4):312-21. PubMed ID: 20595245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
    Paul K; Sathianathen N; Dahm P; Le C; Konety BR
    J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.
    Baquet CR; Ellison GL; Mishra SI
    J Clin Oncol; 2008 Jul; 26(20):3380-6. PubMed ID: 18612153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs.
    Michaeli DT; Michaeli T; Albers S; Michaeli JC
    Target Oncol; 2024 Sep; 19(5):797-809. PubMed ID: 39085451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.
    Hirsch BR; Locke SC; Abernethy AP
    J Oncol Pract; 2016 Apr; 12(4):e350-8. PubMed ID: 27026649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials.
    Le-Rademacher J; Mohile S; Unger J; Hudson MF; Foster J; Lichtman S; Perlmutter J; Dotan E; Extermann M; Dodd K; Tew W; Klepin H; Wildes TM; Sedrak MS; Jatoi A; Little RF
    J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):135-141. PubMed ID: 36519818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.